Rheumatology Advisor

http://RheumatologyAdvisor.com provides healthcare specialists with a valuable resource filled with practical information on rheumatology to aid in their clinical decision-making. Our goal is to support rheumatology professionals by offering detailed and relevant clinical and medication information that aligns with the latest care principles, enabling clinicians to enhance patient outcomes effectively.

Trade/B2B

English

Newsletter (Digital), Online/Digital

Outlet metrics

Domain Authority

Ranking

Global

#592124

United States

#190352

Health/Health

#3617

Traffic sources

Monthly visitors

Articles

Review Affirms Reproductive Safety of Antirheumatic Drugs, Highlights Key Risks

3 days ago | rheumatologyadvisor.com | Hibah Khaja

Results of a large systematic review updating the recommendations for the use of antirheumatic drugs (ARDs) during pregnancy, lactation, and reproduction show that most therapies are generally safe, though some risks persist depending on the drug type and dose, according to findings published in Annals of the Rheumatic Diseases.
Intracranial Involvement in Giant Cell Arteritis Linked to Stroke and Increased Mortality

3 days ago | rheumatologyadvisor.com | Hibah Khaja

A significant number of patients with giant cell arteritis (GCA) experience involvement of the intracranial vessels, a condition that appears to carry a heightened risk for stroke and poor outcomes, according to findings from a systematic review published in Rheumatology. While GCA is classically considered a disease of the large extracranial vessels, emerging evidence indicates that its reach may extend into the brain’s vasculature.
RDW-CV Predicts Coronary Artery Disease in Children With Kawasaki Disease

3 days ago | rheumatologyadvisor.com | Lisa M Kuhns

Red blood cell distribution width-coefficient of variation (RDW-CV) is an independent predictor of coronary artery disease (CAD) among children with Kawasaki disease (KD), and its elevation is associated with lower hemoglobin (Hb) and ferritin levels, according to study results published in Pediatric Rheumatology. Researchers conducted a retrospective case-control study involving patients with KD admitted to a university hospital in Japan between January 2019 and March 2024.
EULAR Updates Guidance for Antirheumatic Drug Use in Reproductive Health

4 days ago | rheumatologyadvisor.com | Lisa M Kuhns

The European Alliance of Associations for Rheumatology (EULAR) released a 2024 update to the existing recommendations for antirheumatic drug use among patients with rheumatic and musculoskeletal diseases (RMDs) who are planning a family, pregnant, breastfeeding, or receiving fertility treatment. The updated guidance appeared in Annals of the Rheumatic Diseases.
ACPA Status in RA Modifies Relationship Between BMI and CV Risk

4 days ago | rheumatologyadvisor.com | Lisa M Kuhns

Body mass index (BMI) is associated with increased cardiovascular risks among patients with anticitrullinated antibody (ACPA)-positive rheumatoid arthritis (RA). While higher BMI is linked to lower cardiovascular risks among ACPA-negative patients, this only applies to those using biologic disease-modifying antirheumatic drugs (bDMARD), according to study results published in RMD Open.
Mesenchymal Precursor Cells Plus Hyaluronic Acid Reduces Chronic LBP, Opioid Use

4 days ago | rheumatologyadvisor.com | Lisa M Kuhns

Treatment with mesenchymal precursor cells (MPCs) plus hyaluronic acid (HA) significantly reduces pain and improves function and quality of life in adults with chronic low back pain (LBP) caused by mild-to-moderate degenerative disc disease (DDD). Benefits remain sustained through 36 months, with no safety concerns compared with control treatment. These study results were published in The Spine Journal.
Type 2 Diabetes and Overweight Status Linked to Reduced Risk for GCA

4 days ago | rheumatologyadvisor.com | Hibah Khaja

Individuals with type 2 diabetes or a higher body mass index (BMI) may face a reduced risk of developing giant cell arteritis (GCA), according to study findings published in Rheumatology. Giant cell arteritis, the most common form of large-vessel vasculitis, typically affects adults aged at least 50 years and is associated with symptoms ranging from headache and jaw pain to vision loss. While cardiovascular comorbidities are common among this population, their role in GCA risk remains unclear.
Levothyroxine Boosts CV Health, Harms Bone Health in Subclinical Hypothyroidism

4 days ago | rheumatologyadvisor.com | Oladimeji Ewumi

Among older adults with subclinical hypothyroidism (SCH), levothyroxine (LT4) therapy can improve cardiovascular health but increase the risk for osteoporosis, fragility fractures, and all-cause mortality, according to study results published in The Journal of Clinical Endocrinology & Metabolism. Thyroid-stimulating hormone (TSH) levels naturally increase with age.
Pipeline Drugs for Vasculitis

1 week ago | rheumatologyadvisor.com | Hibah Khaja

Vasculitis refers to a group of autoimmune diseases that cause inflammation of the blood vessels. This inflammation can result in tissue damage and, in severe cases, lead to organ failure. The classification of vasculitis is primarily based on the size of the affected vessels, including small-, medium-, and large-vessel involvement.
April 2025 Recap: Drug Pipeline Updates

1 week ago | rheumatologyadvisor.com | Steve Duffy

The table below is a review of notable updates that occurred in April 2025 for investigational products in development (not an inclusive list). Click on the status to view our full coverage. DrugPharmacologic ClassProposed IndicationStatusCardiovascular DiseaseSemaglutide (Novo Nordisk)Glucagon-like peptide-1 receptor agonistTo improve walking distance in patients with type 2 diabetes and symptomatic peripheral artery disease.